跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Coxsilv - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Coxsilv
Approved
STANDARD
Coxsilv
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c9347ef320485454
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
c9347ef320485454
Drug Approval Philippines Name
Coxsilv
Product Name
Coxsilv
Registration Number
DRP-2655-03
Brand Name
Coxsilv
Generic Name
Celecoxib
Dosage Form
Capsule
Dosage Strength
200 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Trader
Endurance Healthcare Ltd.
Importer
Ambica International Corporation
Distributor
PHARMASILV TRADING
Issuance Date
26 March 2023
Expiry Date
20 December 2028
Pharmacologic Category
Selective COX-2 Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c9347ef320485454
Type
Standard
Back to Philippines FDA Approvals